Bulky or enlarged uterus ICD-9-CM Coding Information 621.2 is only applicable to female patients. ICD-9-CM Volume 2 Index entries containing back-references to 621.2: Bulky uterus 621.2 Enlargement, enlarged - see also Hypertrophy uterus 621.2 Hyperplasia, hyperplastic myometrium, myometrial 621.2 uterus, uterine (myometrium) 621.2
Hypertrophy of uterus ICD-9-CM 621.2 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 621.2 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Apr 21, 2022 · 621.2 Hypertrophy of uterus ICD-9-CM Vol. 1 Diagnostic Codes 621.2 - Hypertrophy of uterus The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Access to this feature is available in the following products: Find-A-Code Essentials HCC Plus
Oct 01, 2021 · uterus N85.2 Enlargement, enlarged - see also Hypertrophy uterus N85.2 Hyperplasia, hyperplastic uterus, uterine N85.2 myometrium, myometrial N85.2 Hypertrophy, hypertrophic uterus N85.2 myometrium N85.2 Uteromegaly N85.2 Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Uterine fibroids are the most common non-cancerous tumors in women of childbearing age . Fibroids are made of muscle cells and other tissues that grow in and around the wall of the uterus, or womb. The cause of fibroids is unknown. Risk factors include being african-american or being overweight.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
D25.9 is a billable diagnosis code used to specify a medical diagnosis of leiomyoma of uterus, unspecified. The code D25.9 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code D25.9 might also be used to specify conditions or terms like abnormal uterine bleeding due to uterine fibroid, antepartum hemorrhage with uterine leiomyoma, antepartum hemorrhage with uterine leiomyoma - not delivered, benign metastasizing leiomyoma of uterus, benign neoplasm of uterine cervix , cervical fibroid, etc.#N#The code D25.9 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.#N#Unspecified diagnosis codes like D25.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Fibroids are made of muscle cells and other tissues that grow in and around the wall of the uterus, or womb. The cause of fibroids is unknown. Risk factors include being African American or being overweight. Many women with fibroids have no symptoms. If you do have symptoms, they may include.
Uterine Fibroids. Also called: Fibroids, Uterine leiomyomata. Uterine fibroids are the most common benign tumors in women of childbearing age. Fibroids are made of muscle cells and other tissues that grow in and around the wall of the uterus, or womb. The cause of fibroids is unknown.